The global nasal drug delivery devices market size is prognosticated to reach USD 81.85billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Devices Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.
Market Drivers:
Rising Awareness About Nasal Spray and its Benefits will Help Market Gain Impetus
The increasing prevalence of respiratory disorders among people is a major factor boosting the nasal drug delivery devices market growth. Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. Besides this, analyst at Fortune Business Insights™ says, “The increasing patient population and the rising demand for inhalers are encouraging companies to set up new manufacturing units. This is further expected to drive the overall market in the forecast period.”
For More Information:https://www.fortunebusinessinsights.com/industry-reports/nasal-drug-delivery-devices-market-100415
Regional Analysis
Europe to Dominate Owing to Rising Prevalence of Asthma
Geographically, the global nasal drug delivery devices market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. Among these, Europe is holding the largest share with a nasal drug delivery technology market revenue of USD 21.1 billion in 2018. This dominance is attributable to the increasing prevalence of asthma, coupled with the rise in awareness about nasal sprays and their benefits. Besides this, there is the rising popularity of inhalers in developing nations of this region, thereby boosting the regional market.
Apart from this, Asia Pacific market share is likely to attract significant nasal drug delivery devices market share owing to the rise in awareness campaigns about the use of inhalers and its benefits. Moreover, biopharma companies are utilizing novel technologies for introducing MDI and DPI into the regional market for higher revenue generation during the forecast period.
Competitive Landscape –
Demand for Nasal Drug Products to Fuel as Companies Focus on Launching Eco-friendly Inhalers
Manufacturers of the intranasal drug delivery devices are focusing on new product launches to stand out in the market competition and are therefore investing huge sums into research and development for the same. In addition to this, companies are trying to launch environment-friendly inhalers for COPD and asthma patients. They are also promoting advanced technologies by introducing software and advanced services for enhanced user experience. Most of the startup companies in this market are trying to implement applications of agglomerated vesicle technology, particle engineering, nanotechnology, and others for delivering medications to COPD and asthma patients.
More Trending Topics from Fortune Business Insights:
Hyaluronic Acid Based Dermal Fillers Market, Share, Growth, Sales and Drivers Analysis Research Report 2026
The global nasal drug delivery devices market size is prognosticated to reach USD 81.85billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide.
This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Devices Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.An Overview of the Impact of COVID-19 on this Market:The emergence of COVID-19 has brought the world to a standstill.
We understand that this health crisis has brought an unprecedented impact on businesses across industries.
Rising support from governments and several companies can help in the fight against this highly contagious disease.
There are some industries that are struggling and some are thriving.
Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics.
The global nasal drug delivery devices market size is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide.
This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Devices Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.List of Known Nasal Drug Delivery Technology Market Manufacturers include:Consort Medical plc.
(United Kingdom)Teva Pharmaceutical Industries Ltd.H Presspart Manufacturing Ltd.3MGOFIRE INC.NemeraAptarGroup, Inc. (United States)Vectura Group plc (United Kingdom)OthersRequest a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-drug-delivery-devices-market-100415What are the Key Objectives of this Report?The report provides a comprehensive overview of the market for nasal drug delivery systems and its various growth parameters.
Besides this, the report discusses the competitive landscape and lists the names of players operating in the market and the major strategies adopted by them.
Adoption of different strategies will help key players to strive for the leading position in the market.
It also discusses the key segments in the market based on factors such as type, application, end user, distribution channel, and others.
The Global Salmon Calcitonin Market Report is prepared to club all the essential market details such as market size, share, value, growth, restraints, challenges, and opportunities during the study period of 2020-2025.
The data presented in this report has been gathered on the basis of historical data, primary interviews and expert's estimation of future trends.
The report also covers regional assessment which has been conducted globally.
The detailed content of the market study ensures intellectual insights given a better understanding of the untapped opportunities in the market.This report studies the global market size of Salmon Calcitonin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Salmon Calcitonin in these regions.Access Full Report with Table of Contents @ https://www.decisiondatabases.com/ip/5890-salmon-calcitonin-professional-industry-survey-market-reportThe following manufacturers are covered in this report, with sales, revenue, market share for each company:NovartisSanofiMylan PharmaceuticalsApotexUpsher-Smith LaboratoriesFerring PharmaceuticalsPar PharmaceuticalTorrentSun PharmaceuticalUnited Biotech (P) Limited.Shanghai Soho-Yiming PharmaceuticalsSalmon Calcitonin market size by TypeCalcitonin Salmon Nasal SprayCalcitonin Salmon InjectionSalmon Calcitonin market size by ApplicationsHospital PharmaciesRetail PharmaciesOnline PharmaciesMarket size by RegionNorth AmericaUnited StatesCanadaMexicoAsia-PacificChinaJapanSouth KoreaIndiaDownload Free Sample Report of Global Salmon Calcitonin Market @ https://www.decisiondatabases.com/contact/download-sample-5890The study objectives of this report are:To study and analyze the global Salmon Calcitonin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.To understand the structure of Salmon Calcitonin market by identifying its various subsegments.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).Focuses on the key global Salmon Calcitonin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.To project the value and sales volume of Salmon Calcitonin submarkets, with respect to key regions.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.Purchase full Global Salmon Calcitonin Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-5890Other Reports by DecisionDatabases.com:Global Salmon Sausage Market Insights, Forecast to 2025Global Salmon Fish Market Insights, Forecast to 2025About Us:DecisionDatabases.com is a Global business research report provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research Reports, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For More Details:DecisionDatabases.comE-Mail: [email protected]: +91-90-28-057900Web: https://www.decisiondatabases.com/
The Global Rivaroxaban Market Report, with its deep industry analysis of the market, estimates the market size bifurcated into segments and regions.
The Rivaroxaban market share and growth, trends estimated at the end of 2027 give a fair idea of the new opportunities coming up in the market.
The detailed key player's profile and market share analysis give a better understanding of the competitors and their business strategies.Base Year: 2020Estimated Year: 2021Forecast Till: 2027The report classifies the market into different segments based on type and product.
These segments are studied in detail, incorporating the market estimates and forecasts at regional and country levels.
The segment analysis is helpful in understanding the growth areas and potential opportunities of the market.Get | Download FREE Sample Report of Global Rivaroxaban Market @ https://www.decisiondatabases.com/contact/download-sample-6010A special section is dedicated to the analysis of the impact of the COVID-19 pandemic on the growth of the Rivaroxaban market.
The impact is closely studied in terms of production, import, export, and supply.The report covers the complete competitive landscape of the Worldwide Rivaroxaban market with company profiles of key players such as:BayerJWant to add more Company Profiles to the Report?
